Skip to content

Top gainers Top losers Most active Market sectors Heatmap Treasury rates

Earnings calendar IPO calendar Ex-dividend calendar Economic calendar

Congress trades Insider trades Analyst upgrades & downgrades

Screener Compare Backtester

Valuation Fundamentals

Watchlist Portfolio

⌕/

Markets

Stocks Gainers Losers Most active Market sectors Heatmap Earnings calendar Congress trades Insider trades Analyst upgrades/downgrades IPO calendar Ex-dividend calendar

Tools

Screener Compare stocks Returns backtester Portfolio tracker Watchlist Embeddable widget

Metrics

Valuation Fundamentals

Popular lists

Best dividend stocks Best value stocks Largest companies Lowest P/E stocks

Collections

All lists & collections US stocks Japanese stocks Chinese stocks Hong Kong stocks South Korean stocks Taiwanese stocks Canadian stocks UK stocks European stocks Magnificent 7 AI stocks Semiconductor stocks

Compare

Compare stocks Finviz alternative Koyfin alternative TradingView alternative StockAnalysis alternative

Learn

Investing glossary Help & guide

StockMarketCapDocs Token Terms PrivacyData for information only, not investment advice.

◆

Repligen Corporation (RGEN) News - StockMarketCap

Stocks›Repligen Corporation☆

● At closeAs of Jul 2, 2026

Repligen Corporation

RGEN✓

HealthcareMedical - Instruments & SuppliesNASDAQ

$142.40+2.45%

$8.03BMarket cap

150.11xP/E ratio

981.60KVolume (24h)

Overview Forecast Valuation Financials Technical Dividends Smart money News

Price

$142.40

$3.41 (+2.45%) · 24h

Key metrics

Market cap$8.03B+10.84%

Enterprise value$7.81B

Volume (24h)981.60K

P/E ratio (TTM)150.11x

P/S ratio (TTM)10.09x

Dividend yield0.00%

Shares outstanding56.41M

Trading range

Previous close$138.99

Day range$139.90 - $143.17

52-week range$100.99 - $175.77

Repligen Corporation (RGEN) operates in the Medical - Instruments & Supplies industry within the Healthcare sector, listed on NASDAQ.

Similar stocks

Eli Lilly and Company+1.57%

Johnson & Johnson+3.57%

AbbVie Inc.+3.99%

UnitedHealth Group Incorporated-0.28%

Roche Holding AG+3.89%

Merck & Co., Inc.+3.31%

Latest news